TG Therapeutics
TGTX
TGTX
97 hedge funds and large institutions have $359M invested in TG Therapeutics in 2017 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
14.47% more ownership
Funds ownership: 39.64% → 54.11% (+14%)
7% more funds holding
Funds holding: 91 → 97 (+6)
Holders
97
Holding in Top 10
1
Calls
$8.13M
Puts
$4.67M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$31M | |
| 3 | +$22.6M | |
| 4 |
Jennison Associates
New York
|
+$16M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$13.3M |
Top Sellers
| 1 | -$3.55M | |
| 2 | -$3.48M | |
| 3 | -$2.5M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$1.82M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$1.76M |